Organ systems
Professor, Pathology - (Research Scholar Track), Research Professor, BIO5 Institute
The personalized diagnosis, prognosis and treatment of cancer.
Assistant Professor, BIO5 Institute, Assistant Professor, Neuroscience, Assistant Professor, Neuroscience - GIDP
We study how neuronal axons and their terminals respond to stress and damage, and how the molecules activated by stress and damage execute decisions about whether to repair themselves or self-destruct. We hope to identify target molecules that could be used to prevent axon and nerve terminal loss in diseases ranging from diabetic neuropathy to Alzheimer's disease.
Director, Cutaneous Oncology Program, Professor, BIO5 Institute, Professor, Medicine - (Tenure Track)
Professor, BIO5 Institute, Professor, Neuroscience - GIDP, Professor, Pharmacology, Professor, Pharmacology and Toxicology, Professor, Physiological Sciences - GIDP
Assistant Professor, Public Health

Dr. Leslie V. Farland's research program focuses broadly on women’s health and can be categorized into three major themes: i) the intersection between women’s reproductive health and chronic disease risk ii) etiology and risk factors for endometriosis, infertility, and polycystic ovary syndrome iii) disparities in access to infertility care and fertility treatment utilization

Clinical Instructor, Pharmacy Practice-Science, Professor, BIO5 Institute, Professor, Medicine, Professor, Nutritional Sciences, Professor, Physiological Sciences - GIDP
Janet Funk's work includes a focus on metastatic breast cancer that spans the research spectrum from bench to bedside, translational arthritis studies of the pharmacokinetics and safety of turmeric, and collaborative endocrinological studies evaluating the effects of obesity and insulin resistance on bone development in Hispanic girls, as well as effects of obesity on breast cancer risk in older women.
Associate Research Professor
Vijay Gokhale's work includes the use of medicinal chemistry in the development of small molecule therapeutics for neuropathic pain, idiopathic pulmonary fibrosis (IPF), and acute lung injury and cancer.
Regents Professor Emeritus, Professor Emeritus
Our research is centered on the prevention and treatment of our major degenerative diseases. We concentrate on peptide hormones and neurotransmitters and their receptors that are involved in these major diseases. Specific potential applications include pigmentary disorders, melanoma cancer, feeding disorders, pain, sexual function and motivation, and neurodegenerative diseases such as Alzheimer's, Parkinson's, etc.
Chair, Department of Medicine, Professor, BIO5 Institute, Professor, Medicine
Monica Kraft's research focus is in the areas of adult asthma, the role of infection in asthma and the role of the distal lung in asthma and airway remodeling.
Chair, Institutional Animal Care-USE Committee, Director, Agriculture Research Complex, Professor, Animal and Comparative Biomedical Sciences, Professor, BIO5 Institute, Professor, Obstetrics and Gynecology, Professor, Physiological Sciences - GIDP
Our current research program use an integrative approach at the whole animal, isolated organ, cellular and molecular levels to investigate developmental adaptations in pancreatic β-cells and insulin sensitivity that result from early life risk factors, such as intrauterine growth restriction, and increase risk of glucose intolerance and Diabetes in later life.
Assistant Professor, Medicine, Assistant Professor, Physiological Sciences - GIDP, Assistant Research Scientist
Assistant Professor, Medicine, Assistant Professor, Physiology
Assistant Professor, Neuroscience - GIDP, Assistant Professor, Physiological Sciences - GIDP, Associate Professor
Professor, Applied BioSciences - GIDP, Professor, BIO5 Institute, Professor, Cellular and Molecular Medicine, Professor, Genetics - GIDP, Professor, Molecular and Cellular Biology, Professor, Neurology, Professor, Neuroscience, Professor, Neuroscience - GIDP
We are working to uncover the molecular mechanisms of aging and neurodegenerative diseases using a combination of genetic, computational and pharmacological tools, and a diverse array of experimental models. We also seek to develop therapies for ALS and related neurodegenerative diseases.